NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
Mar. 31, 2015
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 4 NOTES PAYABLE On February 28, 2015, the Company entered into a financing arrangement for its directors and officers insurance policy in the amount of $212,400. The financing arrangement bears interest at 6.75% and will be fully paid in 9 months from the date of issuance. As of March 31, 2015, the Company had repaid $23,168 of principal and had paid interest of $1,100 in cash.

NOTES PAYABLE

6 Months Ended

Mar. 31, 2015

NOTE 4 NOTES PAYABLE

On February 28, 2015, the Company entered into a financing arrangement for its directors and officers insurance policy in the amount of $212,400. The financing arrangement bears interest at 6.75% and will be fully paid in 9 months from the date of issuance. As of March 31, 2015, the Company had repaid $23,168 of principal and had paid interest of $1,100 in cash.